Recent advancements in nanoparticle based drug delivery for gastrointestinal disorders
- 7 January 2018
- journal article
- research article
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 15 (3) , 301-318
Abstract
The emergent field of nanoparticles has presented a wealth of opportunities for improving the treatment of human diseases. Recent advances have allowed for promising developments in drug delivery, diagnostics, and therapeutics. Modified delivery systems allow improved drug delivery over traditional pH, microbe, or receptor dependent models, while antibody association allows for more advanced imaging modalities. Nanoparticles have potential clinical application in the field of gastroenterology as they offer several advantages compared to the conventional treatment systems including target drug delivery, enhanced treatment efficacy, and reduced side effects. The aim of this review article is to summarize the recent advancements in developing nanoparticle technologies to treat gastrointestinal diseases. We have covered the application of nanoparticles in various gastrointestinal disorders including inflammatory bowel disease and colorectal cancer. We also have discussed how the gut microbiota affects the nanoparticle based drug delivery in the gastrointestinal tract. Nanoparticles based drug delivery offers a great platform for targeted drug delivery for gastrointestinal disorders. However, it is influenced by the presence of microbiota, drug interaction with nanoparticles, and cytotoxicity of nanoparticles. With the advancements in nanoparticle technology, it may be possible to overcome these barriers leading to efficient drug delivery for gastrointestinal disorders based on nanoparticle platform.Keywords
Funding Information
- FIU-Herbert Wertheim College of Medicine Pilot funding (#800008542)
- Campbell Foundation (# 800008886)
This publication has 76 references indexed in Scilit:
- Small Intestinal Bacterial Overgrowth and Orocecal Transit Time in Patients of Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2013
- Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriersInternational Journal of Nanomedicine, 2012
- Activated fluid transport regulates bacterial-epithelial interactions and significantly shifts the murine colonic microbiomeGut Microbes, 2012
- Targeted polymeric therapeutic nanoparticles: design, development and clinical translationChemical Society Reviews, 2012
- Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agentsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Highly Efficient Drug Delivery with Gold Nanoparticle Vectors for in Vivo Photodynamic Therapy of CancerJournal of the American Chemical Society, 2008
- Drug delivery and nanoparticles: Applications and hazardsInternational Journal of Nanomedicine, 2008
- 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel diseaseJournal of Controlled Release, 2007
- Comparative study of the intestinal mucus barrier in normal and inflamed colonGut, 2007
- Therapeutic potential of nanoparticulate systems for macrophage targetingBiomaterials, 2005